4.6 Review

En bloc resection of extra-peritoneal soft tissue neoplasms incorporating a type III internal hemipelvectomy: a novel approach

期刊

WORLD JOURNAL OF SURGICAL ONCOLOGY
卷 10, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/1477-7819-10-222

关键词

-

向作者/读者索取更多资源

Background: A type III hemipelvectomy has been utilized for the resection of tumors arising from the superior or inferior pubic rami. Methods: In eight patients, we incorporated a type III internal hemipelvectomy to achieve an en bloc R0 resection for tumors extending through the obturator foramen or into the ischiorectal fossa. The pelvic ring was reconstructed utilizing marlex mesh. This allowed for pelvic stability and abdominal wall reconstruction with obliteration of the obturator space to prevent herniations. Results: All eight patients had an R0 resection with an overall survival of 88% and with average follow up of 9.5 years. Functional evaluation utilizing the Enneking classification system, which evaluates motion, pain, stability and strength of the affected extremity, revealed a 62% excellent result and a 37% good result. No significant complications were associated with the operative procedure. Marlex mesh reconstruction provided pelvic stability and eliminated all hernial defects. Conclusion: The superior and inferior pubic rami provide a barrier to a resection for tumors that arise in the extra-peritoneal pelvis extending through the obturator foramen or ischiorectal fossa. Incorporating a type III internal hemipelvectomy with a simple marlex mesh reconstruction allows for complete tumor resection without functional compromise, acute infectious issues, obturator or abdominal hernia defects.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, Research & Experimental

Effect of Sentinel Lymph Node Biopsy andLVIon Merkel Cell Carcinoma Prognosis and Treatment

Jonathan A. Harounian, Nicole Molin, Thomas J. Galloway, Drew Ridge Facs, Jessica Bauman, Jeffrey Farma, Sanjay Reddy, Miriam N. Lango

Summary: This study found that Merkel cell carcinoma patients with lymphovascular invasion (LVI) and positive sentinel lymph node (SLN) had worse prognostic outcomes. Sentinel lymph node biopsy assists in risk stratification and radiation treatment planning in MCC.

LARYNGOSCOPE (2021)

Article Oncology

Treatment at an Academic Cancer Center Confers Better Survival by Stage for Signet-Ring Cell and Non-signet-Ring Cell Gastric Cancer

Maitham A. Moslim, Michael J. Minarich, Mengying Deng, Elizabeth Handorf, Stephanie H. Greco, Sanjay S. Reddy, Jeffrey M. Farma

Summary: This study, based on a large-scale database, compared the overall survival between signet-ring cell gastric carcinoma (SRGC) and non-SRGC (NSRGC) patients treated at academic versus community cancer centers, showing that treatment at academic centers was associated with significant improvements in overall survival.

ANNALS OF SURGICAL ONCOLOGY (2021)

Article Oncology

Predicting positive peritoneal cytology in pancreatic cancer

Eileen A. O'Halloran, Tamsin Board, Max Lefton, Karthik Devarajan, Efrat Dotan, Joshua Meyer, Sanjay S. Reddy

Summary: This study retrospectively analyzed the incidence of positive peritoneal cytology in patients undergoing pancreatectomy for pancreatic adenocarcinoma and identified potential predictors. The findings suggest that elevated Ca19-9 levels at diagnosis, locally advanced disease, and higher BMI may be associated with positive peritoneal cytology.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)

Article Surgery

Clinical and Histological Basis of Adenosquamous Carcinoma of the Pancreas: A 30-year Experience

Maitham A. Moslim, Max D. Lefton, Eric A. Ross, Nicholas Mackrides, Sanjay S. Reddy

Summary: Adenosquamous carcinoma (ASC) of the pancreas is a rare and aggressive malignancy that mainly affects women with a median age of 73 years. Most cases present with tumors in the head of the pancreas, show a wide range of clinical manifestations, and are primarily treated with oncological resection.

JOURNAL OF SURGICAL RESEARCH (2021)

Article Gastroenterology & Hepatology

Obesity affects outcomes of pancreatoduodenectomy

Konstantinos A. Zorbas, Jingwei Wu, Sanjay S. Reddy, Nestor F. Esnaola, Andreas Karachristos

Summary: The study demonstrates that obesity is significantly associated with a higher risk of postoperative complications in patients undergoing PD, and patients with a BMI >= 40 have an increased risk of mortality after PD.

PANCREATOLOGY (2021)

Article Oncology

Neoadjuvant Chemoradiation Impacts the Prognostic Effect of Surgical Margin Status in Pancreatic Adenocarcinoma

Eddie Zhang, Lora Wang, Talha Shaikh, Elizabeth Handorf, J. Karen Wong, John P. Hoffman, Sanjay Reddy, Harry S. Cooper, Steven J. Cohen, Efrat Dotan, Joshua E. Meyer

Summary: This study evaluated the prognostic significance of positive surgical margins (SMs) after NACRT compared with upfront surgery + adjuvant therapy in PAC. The findings suggest that patients with a positive margin after NACRT and surgery had longer survival, indicating that NACRT should be considered for high-risk patients.

ANNALS OF SURGICAL ONCOLOGY (2022)

Article Oncology

Combined Inhibition of AKT and KIT Restores Expression of Programmed Cell Death 4 (PDCD4) in Gastrointestinal Stromal Tumor

Marya Kozinova, Shalina Joshi, Shuai Ye, Martin G. Belinsky, Dinara Sharipova, Jeffrey M. Farma, Sanjay S. Reddy, Samuel Litwin, Karthik Devarajan, Alex Rosa Campos, Yi Yu, Brian Schwartz, Margaret von Mehren, Lori Rink

Summary: This study evaluated the combination of a novel AKT inhibitor, MK-4440, with imatinib mesylate (IM) in gastrointestinal stromal tumor (GIST) cells and preclinical models. The results demonstrated synergistic effects of dual inhibition of KIT and AKT in both IM-sensitive and -resistant GIST cell lines, with enhanced cell death through cell cycle arrest and increased PDCD4 expression. In vivo studies showed superior efficacy of the MK-4440/IM combination in IM-sensitive GIST models, suggesting potential clinical benefits in primary GIST treatment.

CANCERS (2021)

Article Surgery

Association for Academic Surgery Partial Gastrectomy is Associated with Improved Overall Survival in Signet-Ring Cell Gastric Cancer

Maitham A. Moslim, Elizabeth Handorf, Sanjay S. Reddy, Stephanie H. Greco, Jeffrey M. Farma

Summary: Patients with SRGC had better overall survival when undergoing partial gastrectomy compared to total/near-total gastrectomy. Both SRGC and NSRGC patients who underwent partial gastrectomy showed improved survival rates. Overall, partial gastrectomy was associated with better survival compared to total/near-total gastrectomy.

JOURNAL OF SURGICAL RESEARCH (2021)

Article Oncology

Total neoadjuvant therapy is associated with improved overall survival and pathologic response in pancreatic adenocarcinoma

Anthony M. Villano, Eileen O'Halloran, Neha Goel, Karen Ruth, Dany Barrak, Max Lefton, Sanjay S. Reddy

Summary: This study retrospectively evaluated the outcomes of total neoadjuvant therapy (TNT) compared with single modality neoadjuvant therapy (SMNT) or surgery first (SF) for pancreatic ductal adenocarcinoma (PDAC). The results showed that TNT was associated with a higher complete pathologic response rate, a higher rate of margin negative resection, and prolonged overall survival (OS) compared with SF or SMNT.

JOURNAL OF SURGICAL ONCOLOGY (2022)

Article Oncology

Tumor mutational burden and somatic mutation status to predict disease recurrence in advanced melanoma

Meghan J. Hotz, Eileen A. O'Halloran, Maureen Hill, Kelly Hayden, Angela G. Zaladonis, Mengying Deng, Anthony J. Olszanski, Sanjay S. Reddy, Hong Wu, Biao Luo, Jeffrey M. Farma

Summary: Tumor mutational burden (TMB) has been identified as a biomarker for predicting response to immune checkpoint inhibitors in various cancers. This study aimed to evaluate the potential of TMB and somatic mutations in predicting disease recurrence in melanoma. The results showed that TMB-L tumors and mutations in BRAF and NRAS were associated with higher risk of recurrence.

MELANOMA RESEARCH (2022)

Meeting Abstract Oncology

Type of Neoadjuvant Treatment is Associated with Increased Pancreatic Fibrosis and Oncologic Outcomes

Sai P. Reddy, Anthony Villano, Karthik Devarajan, Dany Barrak, Sanjay S. Reddy

ANNALS OF SURGICAL ONCOLOGY (2022)

Meeting Abstract Gastroenterology & Hepatology

PANCREATICOJEJUNOSTOMY: INTRODUCING A NOVEL TECHNIQUE WITH LOW PANCREATIC FISTULA RATE

Maitham A. Moslim, Max D. Lefton, Eileen A. O'Halloran, Eric A. Ross, Tamsin Board, Andreas Karachristos, Sanjay S. Reddy

GASTROENTEROLOGY (2021)

Article Oncology

Hepatobiliary Cancers, Version 2.2021

Al B. Benson III, Michael I. D'Angelica, Daniel E. Abbott, Daniel A. Anaya, Robert Anders, Chandrakanth Are, Melinda Bachini, Mitesh Borad, Daniel Brown, Adam Burgoyne, Prabhleen Chahal, Daniel T. Chang, Jordan Cloyd, Anne M. Covey, Evan S. Glazer, Lipika Goyal, William G. Hawkins, Renuka Iyer, Rojymon Jacob, R. Kate Kelley, Robin Kim, Matthew Levine, Manisha Palta, James O. Park, Steven Raman, Sanjay Reddy, Vaibhav Sahai, Tracey Schefter, Gagandeep Singh, Stacey Stein, Jean-Nicolas Vauthey, Alan P. Venook, Adam Yopp, Nicole R. McMillian, Cindy Hochstetler, Susan D. Darlow

Summary: The NCCN Guidelines for Hepatobiliary Cancers provide recommendations for screening, diagnosis, staging, treatment, and management of HCC, gallbladder cancer, and cancer of the bile ducts. A multidisciplinary evaluation is crucial for determining optimal treatment strategies, with significant advancements in systemic treatment of HCC beyond traditional options like sorafenib.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)

Article Oncology

Pancreatic cancer in the era of COVID-19 pandemic: Which one is the lesser of two evils?

Maitham A. Moslim, Michael J. Hall, Joshua E. Meyer, Sanjay S. Reddy

Summary: Amid the COVID-19 pandemic, there is a paradigm shift in the treatment of pancreatic cancer to adapt to the new health threat. Utilizing neoadjuvant treatment and safe surgery in a controlled environment can improve oncological outcomes, whereas oncologic procedures in hazardous settings might shorten patient survival if complicated by COVID-19 infection.

WORLD JOURNAL OF CLINICAL ONCOLOGY (2021)

暂无数据